241 related articles for article (PubMed ID: 31680725)
21. Immunotherapy and the Interventional Oncologist: Challenges and Opportunities-A Society of Interventional Oncology White Paper.
Erinjeri JP; Fine GC; Adema GJ; Ahmed M; Chapiro J; den Brok M; Duran R; Hunt SJ; Johnson DT; Ricke J; Sze DY; Toskich BB; Wood BJ; Woodrum D; Goldberg SN
Radiology; 2019 Jul; 292(1):25-34. PubMed ID: 31012818
[TBL] [Abstract][Full Text] [Related]
22. Combination of radiotherapy and immune checkpoint inhibitors.
Pilones KA; Vanpouille-Box C; Demaria S
Semin Radiat Oncol; 2015 Jan; 25(1):28-33. PubMed ID: 25481263
[TBL] [Abstract][Full Text] [Related]
23. Oncology meets immunology: the cancer-immunity cycle.
Chen DS; Mellman I
Immunity; 2013 Jul; 39(1):1-10. PubMed ID: 23890059
[TBL] [Abstract][Full Text] [Related]
24. Priming is key to effective incorporation of image-guided thermal ablation into immunotherapy protocols.
Silvestrini MT; Ingham ES; Mahakian LM; Kheirolomoom A; Liu Y; Fite BZ; Tam SM; Tucci ST; Watson KD; Wong AW; Monjazeb AM; Hubbard NE; Murphy WJ; Borowsky AD; Ferrara KW
JCI Insight; 2017 Mar; 2(6):e90521. PubMed ID: 28352658
[TBL] [Abstract][Full Text] [Related]
25. Interplay between Immune Checkpoint Proteins and Cellular Metabolism.
Lim S; Phillips JB; Madeira da Silva L; Zhou M; Fodstad O; Owen LB; Tan M
Cancer Res; 2017 Mar; 77(6):1245-1249. PubMed ID: 28246276
[TBL] [Abstract][Full Text] [Related]
26. Heat-Based Tumor Ablation: Role of the Immune Response.
Wu F
Adv Exp Med Biol; 2016; 880():131-53. PubMed ID: 26486336
[TBL] [Abstract][Full Text] [Related]
27. PET Assessment of Immune Effects from Interventional Oncology Procedures.
Hunt SJ; Seraj SM; Alavi A
PET Clin; 2019 Oct; 14(4):477-485. PubMed ID: 31472745
[TBL] [Abstract][Full Text] [Related]
28. Image-guided high-dose-rate brachytherapy of malignancies in various inner organs - technique, indications, and perspectives.
Bretschneider T; Ricke J; Gebauer B; Streitparth F
J Contemp Brachytherapy; 2016 Jun; 8(3):251-61. PubMed ID: 27504135
[TBL] [Abstract][Full Text] [Related]
29. High-Intensity Focused Ultrasound: Current Status for Image-Guided Therapy.
Copelan A; Hartman J; Chehab M; Venkatesan AM
Semin Intervent Radiol; 2015 Dec; 32(4):398-415. PubMed ID: 26622104
[TBL] [Abstract][Full Text] [Related]
30. Thermal ablation and immunomodulation: From preclinical experiments to clinical trials.
Takaki H; Cornelis F; Kako Y; Kobayashi K; Kamikonya N; Yamakado K
Diagn Interv Imaging; 2017 Sep; 98(9):651-659. PubMed ID: 28579522
[TBL] [Abstract][Full Text] [Related]
31. Targeting the Immune Niche within the Bone Marrow Microenvironment: The Rise of Immunotherapy in Multiple Myeloma.
Podar K; Jager D
Curr Cancer Drug Targets; 2017; 17(9):782-805. PubMed ID: 28201977
[TBL] [Abstract][Full Text] [Related]
32. The use of radiofrequency ablation in pancreatic cancer in the midst of the dawn of immuno-oncology.
Reccia I; Kumar J; Habib N; Sodergren M
Med Oncol; 2018 Oct; 35(12):151. PubMed ID: 30284649
[TBL] [Abstract][Full Text] [Related]
33. Small Molecular Immune Modulators as Anticancer Agents.
Han Y; Zhu L; Wu W; Zhang H; Hu W; Dai L; Yang Y
Adv Exp Med Biol; 2020; 1248():547-618. PubMed ID: 32185725
[TBL] [Abstract][Full Text] [Related]
34. Biotech and Breakthroughs in Immuno-Oncology.
Bockman JM
Urol Clin North Am; 2020 Nov; 47(4):511-521. PubMed ID: 33008500
[TBL] [Abstract][Full Text] [Related]
35. Interventional therapy combined with immune checkpoint inhibitors: Emerging opportunities for cancer treatment in the era of immunotherapy.
Chang X; Lu X; Guo J; Teng GJ
Cancer Treat Rev; 2019 Mar; 74():49-60. PubMed ID: 30831375
[TBL] [Abstract][Full Text] [Related]
36. Pharmacologic Modulation of Human Immunity in the Era of Immuno-oncology: Something Old, Something New.
Bangalore Kumar A; Maus R; Markovic SN
Mayo Clin Proc; 2018 Jul; 93(7):917-936. PubMed ID: 29887221
[TBL] [Abstract][Full Text] [Related]
37. Microwave ablation combined with OK-432 induces Th1-type response and specific antitumor immunity in a murine model of breast cancer.
Li L; Wang W; Pan H; Ma G; Shi X; Xie H; Liu X; Ding Q; Zhou W; Wang S
J Transl Med; 2017 Jan; 15(1):23. PubMed ID: 28137271
[TBL] [Abstract][Full Text] [Related]
38. Nucleic Acid Sensing Machinery: Targeting Innate Immune System for Cancer Therapy.
Iurescia S; Fioretti D; Rinaldi M
Recent Pat Anticancer Drug Discov; 2018; 13(1):2-17. PubMed ID: 29086701
[TBL] [Abstract][Full Text] [Related]
39. Immuno-oncology in head and neck squamous cell cancers: News from clinical trials, emerging predictive factors and unmet needs.
Cavalieri S; Rivoltini L; Bergamini C; Locati LD; Licitra L; Bossi P
Cancer Treat Rev; 2018 Apr; 65():78-86. PubMed ID: 29574334
[TBL] [Abstract][Full Text] [Related]
40. Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy.
Pitt JM; Marabelle A; Eggermont A; Soria JC; Kroemer G; Zitvogel L
Ann Oncol; 2016 Aug; 27(8):1482-92. PubMed ID: 27069014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
